Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0170
0.00 (0.00%)
Jul 15, 2026, 10:16 AM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 22.4 million as of July 14, 2026. Its market cap has increased by 25.54% in one year.
Market Cap
22.40M
Enterprise Value
16.06M
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 22.40M, a decrease of -10.71%. That is a compound annual growth rate of -1.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 22.40M | 23.44% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imugene | 43.66M |
| Proteomics International Laboratories | 33.86M |
| Noxopharm | 27.96M |
| Patrys | 26.66M |
| Algorae Pharmaceuticals | 26.33M |
| NeuroScientific Biopharmaceuticals | 21.62M |
| EZZ Life Science Holdings | 21.18M |
| Argenica Therapeutics | 16.06M |